99% Savings - Buy Just @1 Rs X
Eclin is a prescription medicine that is available as a Injection. Secondary and off-label uses of Eclin have also been mentioned below.
The right dosage of Eclin depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Eclin include Diarrhoea, Stomach Upset. While these are the most often observed Eclin side effects, there are can be others also. These have been listed below. Such side effects of Eclin normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Eclin's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Eclin related warnings talks about Eclin's effects on the liver, heart and kidney.
Eclin is contraindicated in people with pre-existing medical conditions like Allergy as it can result in adverse effects. Other conditions have been mentioned below in the Eclin contraindications section.
Besides this, Eclin may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Eclin is considered safe while driving, and is addictive.
Eclin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Eclin safe for pregnant women?
Eclin is safe to take during pregnancy.
Is the use of Eclin safe during breastfeeding?
Eclin does not show any side effects in breastfeeding women.
What is the effect of Eclin on the Kidneys?
Eclin may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Eclin on the Liver?
There is no research available on the side effects of Eclin on the liver. Therefore, its impact is unknown.
What is the effect of Eclin on the Heart?
There is no research available on the side effects of Eclin on the heart. Therefore, its impact is unknown.
Eclin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Unknown
If you are suffering from any of the following diseases, you should not take Eclin unless your doctor advises you to do so -
Is this Eclin habit forming or addictive?
No, you will not get addicted to Eclin.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Eclin as it does not make you drowsy.
Is it safe?
Yes, but take Eclin only as per medical advice.
Is it able to treat mental disorders?
No, the use of Eclin in mental disorders is not effective.
Interaction between Food and Eclin
Taking Eclin with food does not cause any problems.
Interaction between Alcohol and Eclin
Consuming Eclin with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cefobid® (sterile cefoperazone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162